UnitedHealth Group Incorporated $UNH Shares Sold by Convergence Financial LLC

Key Points

• Convergence Financial reduced its UnitedHealth Group stake by 52.8% in the third quarter, selling 2,819 shares and retaining 2,522 shares valued at approximately $926,000.
• Despite Convergence’s reduction, several major institutions increased their positions, and institutional investors collectively own 87.86% of UnitedHealth’s shares.
• UnitedHealth reported quarterly EPS of $4.69, beating estimates by $0.55, and revenue of $112.70 billion. The company also maintains a quarterly dividend of $2.32 per share, while analysts hold a consensus “Moderate Buy” rating with a $463.93 price target.

Convergence Financial LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 52.8% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,522 shares of the healthcare conglomerate's stock after selling 2,819 shares during the period. Convergence Financial LLC's holdings in UnitedHealth Group were worth $926,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. BlackRock Inc. increased its holdings in UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock valued at $31,946,594,000 after buying an additional 3,395,530 shares during the last quarter. State Street Corp raised its position in UnitedHealth Group by 0.7% in the second quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate's stock worth $18,966,555,000 after acquiring an additional 301,081 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of UnitedHealth Group by 6.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate's stock worth $4,449,317,000 after acquiring an additional 616,723 shares during the last quarter. Wellington Management Group LLP grew its position in shares of UnitedHealth Group by 5.8% during the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate's stock valued at $4,436,923,000 after acquiring an additional 583,536 shares during the period. Finally, Corient Private Wealth LP grew its position in shares of UnitedHealth Group by 1,443.7% during the 2nd quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate's stock valued at $3,510,920,000 after acquiring an additional 7,900,011 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

UNH opened at $406.81 on Thursday. The company has a 50 day simple moving average of $389.32 and a two-hundred day simple moving average of $361.74. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The firm has a market cap of $365.15 billion, a P/E ratio of 23.23, a PEG ratio of 1.51 and a beta of 0.60. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.70 billion for the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company's revenue was down .4% on a year-over-year basis. During the same period last year, the firm earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 20.62 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were paid a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date was Monday, September 14th. UnitedHealth Group's dividend payout ratio is presently 53.00%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the firm's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company's stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.19% of the company's stock.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Long-term earnings estimates increased. Zacks Research raised its FY2027 EPS forecast to $23.29 from $22.28 and its FY2028 estimate to $26.60 from $25.74, signaling improved expectations for UnitedHealth’s future profitability.
• Positive Sentiment: Morgan Stanley lifted its price target. The firm increased its target to $531 from $529 and maintained an “Overweight” rating, implying substantial potential upside from recent trading levels. Morgan Stanley Adjusts Price Target on UnitedHealth Group
• Neutral Sentiment: Near-term estimates were mixed. Zacks raised its Q2 2027 EPS forecast to $6.62 from $6.35, but slightly reduced its Q4 2026 estimate to $2.24 from $2.25. Zacks continues to rate UNH “Hold,” indicating limited conviction despite stronger longer-term projections.
• Neutral Sentiment: Fraud-prevention collaboration highlights operational opportunities. UnitedHealth and Codoxo plan to present AI-based methods for identifying healthcare fraud beyond traditional claims data. The initiative could support payment integrity and cost control, though it is not expected to materially affect near-term results. Codoxo and UnitedHealth Group fraud presentation
• Negative Sentiment: Investor uncertainty remains elevated. A law firm is soliciting shareholders over allegations concerning potential insider fiduciary-duty violations. The notice does not establish wrongdoing, but such announcements can add reputational and legal-risk concerns. UnitedHealth shareholder legal notice
• Negative Sentiment: Industry margin pressure remains a concern. A comparison with Molina Healthcare points to elevated medical costs and membership-related pressure across managed-care companies, factors that could weigh on UnitedHealth’s near-term margins even as its recent earnings exceeded expectations. Molina Healthcare versus Elevance Health and UnitedHealth

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on UNH shares. Oppenheimer raised their target price on UnitedHealth Group from $420.00 to $500.00 and gave the stock an "outperform" rating in a report on Friday, July 17th. HSBC lifted their target price on UnitedHealth Group from $300.00 to $380.00 and gave the company a "hold" rating in a research report on Monday, July 6th. Barclays cut their price target on UnitedHealth Group from $441.00 to $440.00 and set an "overweight" rating for the company in a report on Wednesday, October 14th. KeyCorp restated an "overweight" rating on shares of UnitedHealth Group in a research report on Wednesday, October 14th. Finally, The Goldman Sachs Group raised their price objective on UnitedHealth Group from $435.00 to $490.00 and gave the stock a "buy" rating in a research note on Friday, July 17th. Twenty investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus target price of $463.93.

UnitedHealth Group Profile

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.